BioLife Solutions (BLFS)
(Delayed Data from NSDQ)
$18.15 USD
+0.12 (0.67%)
Updated May 6, 2024 04:00 PM ET
After-Market: $18.15 0.00 (0.00%) 6:00 PM ET
3-Hold of 5 3
D Value B Growth D Momentum C VGM
Brokerage Reports
0 items in cart
BioLife Solutions, Inc. [BLFS]
Reports for Purchase
Showing records 61 - 80 ( 91 total )
Company: BioLife Solutions, Inc.
Industry: Medical - Products
2019 Financials Reported; Rocky Terrain Ahead; Lowering PT to $17
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: BioLife Solutions, Inc.
Industry: Medical - Products
Multiple Recent Acquisitions Bolster Trajectory; Reiterate Buy and Raising Target to $26
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: BioLife Solutions, Inc.
Industry: Medical - Products
Co-Investment Accelerator Program Established; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: BioLife Solutions, Inc.
Industry: Medical - Products
2Q19 Financial Results Reported; Top- and Bottom- Line In-Line; Guidance Modestly Improved; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: BioLife Solutions, Inc.
Industry: Medical - Products
SAVSU Partnership With United Cargo; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: BioLife Solutions, Inc.
Industry: Medical - Products
Powered by Cell and Gene Therapy Manufacturing Industry Growth; Initiating at Buy and $23 Price Target
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R